Annie Hung

967 total citations
32 papers, 335 citations indexed

About

Annie Hung is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Annie Hung has authored 32 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Annie Hung's work include Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (8 papers) and Renal cell carcinoma treatment (5 papers). Annie Hung is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (8 papers) and Renal cell carcinoma treatment (5 papers). Annie Hung collaborates with scholars based in United States, Canada and Australia. Annie Hung's co-authors include Sarah Visintini, F. Daniel Ramirez, Pietro Di Santo, Simon Parlow, Graeme Prosperi‐Porta, Benjamin Hibbert, Richard G. Jung, Trevor Simard, Aung Naing and Johanna C. Bendell and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Annie Hung

31 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Hung United States 8 124 68 56 49 42 32 335
Asfandyar Sheikh Pakistan 11 75 0.6× 57 0.8× 72 1.3× 47 1.0× 26 0.6× 25 500
Mostafa Eltobgy United States 14 69 0.6× 57 0.8× 51 0.9× 116 2.4× 41 1.0× 25 482
Michaël McCarthy United States 9 65 0.5× 85 1.3× 25 0.4× 40 0.8× 55 1.3× 50 356
Han‐Ik Cho South Korea 13 49 0.4× 29 0.4× 61 1.1× 122 2.5× 26 0.6× 67 463
Janna Manjelievskaia United States 12 103 0.8× 69 1.0× 26 0.5× 59 1.2× 23 0.5× 39 420
Jung Lim Lee South Korea 12 105 0.8× 53 0.8× 31 0.6× 64 1.3× 16 0.4× 33 480
L. Lévy-Bachelot France 11 93 0.8× 34 0.5× 15 0.3× 81 1.7× 36 0.9× 49 393
Mary Coerver- Connolly Ireland 9 97 0.8× 39 0.6× 97 1.7× 25 0.5× 10 0.2× 17 420
Phung-Anh Nguyen Taiwan 8 37 0.3× 62 0.9× 15 0.3× 48 1.0× 39 0.9× 14 304
John Firth United Kingdom 10 107 0.9× 240 3.5× 131 2.3× 118 2.4× 36 0.9× 20 778

Countries citing papers authored by Annie Hung

Since Specialization
Citations

This map shows the geographic impact of Annie Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Hung more than expected).

Fields of papers citing papers by Annie Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Hung. The network helps show where Annie Hung may publish in the future.

Co-authorship network of co-authors of Annie Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Hung. A scholar is included among the top collaborators of Annie Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Hung. Annie Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Annie, Michael Slawnych, & Caroline McGuinty. (2025). Enhancing Care in Cardiogenic Shock: Role of Palliative Care in Acute Cardiogenic Shock Through Destination Therapy. Canadian Journal of Cardiology. 41(4). 669–681.
2.
Fogarty, Michael P., Annie Hung, Mervyn Kyi, et al.. (2024). High prevalence of diabetes in a regional Australian hospital highlights the need to prioritise inpatient diabetes care. Internal Medicine Journal. 54(8). 1405–1408. 1 indexed citations
3.
Alexander, Bryce, Sanoj Chacko, Hoshiar Abdollah, et al.. (2023). Implantable Cardioverter-defibrillator Deactivation at Distance for the Dignity of Dying (the 4D Project). Circulation Arrhythmia and Electrophysiology. 16(10). e012309–e012309. 3 indexed citations
4.
Jung, Richard G., Pietro Di Santo, Graeme Prosperi‐Porta, et al.. (2021). Methodological quality of COVID-19 clinical research. Nature Communications. 12(1). 943–943. 107 indexed citations
5.
Tannir, Nizar M., Kyriakos P. Papadopoulos, Deborah J. Wong, et al.. (2021). Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study. International Journal of Cancer. 149(2). 403–408. 29 indexed citations
6.
Hung, Annie, Ankur Gupta, Alexandra Davis, et al.. (2021). Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 106(8). 2423–2435. 40 indexed citations
8.
Wainberg, Zev A., Kynan Feeney, Myung Ah Lee, et al.. (2019). Meta-analysis of OS for pancreatic cancer patients receiving 5FU and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy.. Journal of Clinical Oncology. 37(4_suppl). 202–202. 2 indexed citations
9.
Garon, Edward B., David T. Wong, Jeffrey Schneider, et al.. (2018). MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-PD-1. Journal of Thoracic Oncology. 13(10). S366–S367. 1 indexed citations
10.
Autio, Karen A., Aung Naing, Annie Hung, et al.. (2018). Durability of clinical benefit in metastatic epithelial ovarian cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. Annals of Oncology. 29. viii408–viii408. 2 indexed citations
11.
Hecht, J. Randolph, Aung Naing, Gerald S. Falchook, et al.. (2018). Overall survival of PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).. Journal of Clinical Oncology. 36(4_suppl). 374–374. 11 indexed citations
12.
Hecht, J. Randolph, Aung Naing, Gerald S. Falchook, et al.. (2017). Overall survival and immunologic responses in metastatic pancreatic adenocarcinoma (PDAC) on PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX). Annals of Oncology. 28. v254–v254. 1 indexed citations
13.
Naing, Aung, Gerald S. Falchook, Manish R. Patel, et al.. (2017). Immunologic and objective tumor responses to PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC). Annals of Oncology. 28. iii138–iii138. 1 indexed citations
14.
Naing, Aung, Deborah Jean Lee Wong, Jeffrey R. Infante, et al.. (2017). PEGylated human IL-10 (AM0010) in combination with pembrolizumab in anti-PD1 and CTLA-4 refractory melanoma.. Journal of Clinical Oncology. 35(15_suppl). 3084–3084. 3 indexed citations
15.
Wong, Deborah J., Jeffrey Schneider, Raid Aljumaily, et al.. (2017). PEGylated human IL-10 (AM0010) in combination with an anti-PD-1 in advanced NSCLC. Annals of Oncology. 28. xi3–xi3. 1 indexed citations
16.
Naing, Aung, Jon Infante, Deborah J. Wong, et al.. (2017). Efficacy of PEGylated human IL-10 (AM0010) in combination with anti-PD-1 blockade in patients (pts) with metastatic renal cell carcinoma (mRCC): A phase 1b trial. Annals of Oncology. 28. xi1–xi1. 1 indexed citations
17.
Butler, Matthew, et al.. (2017). Delays in treatment for colorectal cancer patients in an NCI-designated cancer center serving a Hispanic majority community.. Journal of Clinical Oncology. 35(8_suppl). 178–178. 1 indexed citations
18.
Solanki, Guirish A., Peter P. Sun, Kenneth W. Martin, et al.. (2016). Cervical cord compression in mucopolysaccharidosis VI (MPS VI): Findings from the MPS VI Clinical Surveillance Program (CSP). Molecular Genetics and Metabolism. 118(4). 310–318. 28 indexed citations
19.
Hung, Annie. (2015). Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review. World Journal of Gastroenterology. 21(42). 12197–12197. 49 indexed citations
20.
Hung, Annie, et al.. (2015). Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation. SHILAP Revista de lepidopterología. 2015. 1–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026